World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
39586
World Ranking
7947
National Ranking
4133

Julie Teruya-Feldstein publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Julie Teruya-Feldstein sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 294 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Julie Teruya-Feldstein D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Julie Teruya-Feldstein sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Julie Teruya-Feldstein is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research predominantly focuses on medicine, with significant contributions in oncology, pathology and forensic medicine, hematology, genetics, and immunology.

Their work covers a variety of topics, including:

  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Viral-associated cancers and disorders
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction

Julie Teruya-Feldstein has published extensively in several venues. Frequent publication venues include:

  • Blood
  • Blood Advances
  • Nature Medicine
  • Proceedings of the National Academy of Sciences
  • Cancer Discovery

Some of the recent papers authored or co-authored by Julie Teruya-Feldstein are:

  • "Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy", 2021, published in Nature Medicine
  • "Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma", 2021, published in Proceedings of the National Academy of Sciences
  • "Integrative RNA-omics Discovers GNAS Alternative Splicing as a Phenotypic Driver of Splicing Factor-Mutant Neoplasms", 2021, published in Cancer Discovery
  • "NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss", 2022, published in EMBO Reports
  • "Atypical lymphocyte morphology in SARS-CoV-2 infection", 2020, published in Pathology - Research and Practice

Frequent collaborators with Julie Teruya-Feldstein include:

  • Christian Salib (8 joint publications)
  • Siraj M. El Jamal (5 joint publications)
  • Vesna Najfeld (5 joint publications)
  • Sundar Jagannath (4 joint publications)
  • Samir Parekh (4 joint publications)

Best Publications

  • Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

    Li Ma;Julie Teruya-Feldstein;Robert A. Weinberg

  • Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer

    Arkaitz Carracedo;Li Ma;Li Ma;Li Ma;Julie Teruya-Feldstein;Federico Rojo

  • miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

    Li Ma;Jennifer Young;Harsha Prabhala;Elizabeth Pan

  • Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

    Li Ma;Ferenc Reinhardt;Elizabeth Pan;Jürgen Soutschek

  • SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization

    Lydia W.S. Finley;Arkaitz Carracedo;Jaewon Lee;Amanda Souza

  • Ubiquitination regulates PTEN nuclear import and tumor suppression

    Lloyd C. Trotman;Xinjiang Wang;Andrea Alimonti;Zhenbang Chen

  • Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in Mice

    Rocío Sotillo;Eva Hernando;Elena Díaz-Rodríguez;Julie Teruya-Feldstein

  • p63 Expression Profiles in Human Normal and Tumor Tissues

    Charles J. Di Como;Marshall J. Urist;Irina Babayan;Marija Drobnjak

  • PML targeting eradicates quiescent leukaemia-initiating cells

    Keisuke Ito;Rosa Bernardi;Alessandro Morotti;Sahoko Matsuoka

  • RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer

    Andrew L Wolfe;Kamini Singh;Yi Zhong;Philipp Drewe

  • The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.

    Min Sup Song;Leonardo Salmena;Arkaitz Carracedo;Ainara Egia

  • Dissecting eIF4E action in tumorigenesis

    Hans-Guido Wendel;Ricardo L.A. Silva;Abba Malina;John R. Mills

  • Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants

    Michael T. Hemann;Anka Bric;Julie Teruya-Feldstein;Andreas Herbst

  • Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts

    Aruna Kode;John S. Manavalan;Ioanna Mosialou;Govind Bhagat

  • Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

    Tarun Kewalramani;Andrew D. Zelenetz;Stephen D. Nimer;Carol Portlock

  • Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.

    Christina Gewinner;Zhigang C. Wang;Andrea Richardson;Julie Teruya-Feldstein

  • Role of the proto-oncogene Pokemon in cellular transformation and ARF repression

    Takahiro Maeda;Robin M. Hobbs;Taha Merghoub;Ilhem Guernah

  • Skp2 targeting suppresses tumorigenesis by Arf-p53- independent cellular senescence

    Hui Kuan Lin;Zhenbang Chen;Zhenbang Chen;Zhenbang Chen;Guocan Wang;Caterina Nardella;Caterina Nardella

  • Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

    Ferenc Reinhardt;Elizabeth Pan;Jürgen Soutschek;Balkrishen Bhat

  • Tumour invasion and metastasis initiated by microRNA-10b in breast cancer (Nature (2007) 449, (682-688))

    Li Ma;Julie Teruya-Feldstein;Robert A. Weinberg

Frequent Co-Authors

Pier Paolo Pandolfi
Pier Paolo Pandolfi Beth Israel Deaconess Medical Center
Andrew D. Zelenetz
Andrew D. Zelenetz Memorial Sloan Kettering Cancer Center
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Craig H. Moskowitz
Craig H. Moskowitz University of Miami
Giovanna Tosato
Giovanna Tosato National Institutes of Health
Stephen D. Nimer
Stephen D. Nimer University of Miami
Ross L. Levine
Ross L. Levine Memorial Sloan Kettering Cancer Center
Carlos Cordon-Cardo
Carlos Cordon-Cardo Icahn School of Medicine at Mount Sinai
Madhav V. Dhodapkar
Madhav V. Dhodapkar Emory University
Mark Raffeld
Mark Raffeld National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or complementary online degrees in the healthcare field can help expand your career opportunities in medicine. Many students consider an online mha programs affordable option, which prepares graduates for leadership roles in healthcare management and administration.

For registered nurses looking to advance their practice and impact patient care, cheap dnp online programs offer a flexible way to earn a Doctor of Nursing Practice without stepping away from current work commitments.

Those interested in pharmacy can pursue pharm d online programs, which open doors to advanced clinical and research roles in the pharmaceutical field, all with the convenience of distance learning.

Additionally, individuals who wish to work in medical data and technology can benefit from rhit programs online. These programs train you in managing health records and information systems, a sector with rapidly growing demand.

By considering these related online degrees, students and professionals can find flexible education options that align with diverse career pathways in the healthcare sector.

Best Scientists Citing Julie Teruya-Feldstein

Trending Scientists

Recently Published Articles